January 17, 2024 · Form 4 insider transaction
Carr Patricia bought 1,327 shares of Jazz Pharmaceuticals plc at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Represents ordinary shares of Jazz Pharamceuticals that will be delivered pursuant to the terms of performance share awards made to the reporting person on May 5, 2021. The performance-based vesting requirements applicable to such awards were satisfied on January 17, 2024, which represents the date on which the level of performance attained was certified.; The Reporting Person acquired 50 ordinary shares under a Section 423 Employee Stock Purchase Plan on November 30, 2023.